NetTargets
PrivateLast Round
VC Round
May 1, 2024
Total Funding Raised
$7.17M
Company Overview
NetTargets is a biotechnology company that provides a drug discovery platform based on AI-enhanced systems biology to identify novel drug targets and simulate treatment strategies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NetTargets Comparables
Compare NetTargets with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Callio Therapeutics | 83% | |
| Phrontline Biopharma | 83% | |
| Eli Lilly and Company | 75% | |
NetTargets Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2024 | ||||
| Series A | Jun 28, 2021 | ||||
| Pre Seed | Apr 16, 2020 | ||||
| Seed | Oct 25, 2019 |
NetTargets Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A |
| CKD Venture Capital | Series A |
| Bluepoint Partners | Seed |
| Friend Investment Partners | Pre Seed, Series A |
| GU Equity Partners | Series A |
| We Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Developing dual-payload ADCs with Debiopharm to treat resistant cancers.
- Oct 30, 2025
Collaborating with Debiopharm on dual-payload Antibody-Drug Conjugates (ADCs).
NetTargets Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NetTargets's valuation, stock price, and market status.